
LAS VEGAS — Apple and OpenEvidence on Sunday launched a study based around an experimental artificial intelligence-powered health chat application, hinting at possible new directions for both companies.
Sumbul Desai, Apple’s vice president of health and fitness, explained that the company’s commitment to scientific rigor motivated the study, which aims to better understand how consumers interact with conversational health AI chatbots. “We’re studying what builds user trust, how people comprehend responses, the quality of responses, and we wanted to work with a clinically grounded partner, and that is OpenEvidence,” she said during the partnership announcement on stage at the HLTH conference in Las Vegas.
“OpenEvidence is the most trusted and loved brand product among doctors. Apple is the most trusted and loved brand and product among consumers, and especially health consumers,” said OpenEvidence CEO Daniel Nadler at the event. “So you have to bring these two things together. It’s like peanut butter and jelly.”

This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in